Fatima Laher

Also affiliated with Perinatal HIV Research Unit

Immunology and MicrobiologyMedicineHealth ProfessionsSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data quality in an HIV vaccine efficacy clinical trial in South Africa: through natural disasters and with discipline

BMC Medical Research Methodology(2023)10.1186/s12874-023-01967-9

Top 100%

0DataRank

Top 100%0 citations

Mookho Malahleha, Shelly Ramirez, William Brumskine, Kennedy Otwombe, Zoe Moodie +2 more

Papers

Driven by 24 papers — median percentile 0. Top paper: “Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition”.

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

New England Journal of Medicine(2021)10.1056/nejmoa2031738

N/A

6.2DataRank · unranked

547 citations

Peter B. Gilbert, Michal Juraska, David C. Montefiori, Lynn Morris, Shelly Karuna +40 more

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial

The Lancet Infectious Diseases(2024)10.1016/s1473-3099(24)00358-x

N/A

1.3DataRank · unranked

40 citations

Kathryn Mngadi, Ludo Lavreys, Steven Nijs, Peter B. Gilbert, John Hural +60 more

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

PLoS Medicine(2020)10.1371/journal.pmed.1003038

N/A

1.2DataRank · unranked

48 citations

Zoe Moodie, Kristen W. Cohen, Nicole Grunenberg, Linda‐Gail Bekker, Mary Allen +26 more

Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac260

N/A

1.1DataRank · unranked

50 citations

One Dintwe, Sheetal Sawant, Doug Grove, Yunda Huang, Holly Janes +43 more

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial

PLoS Medicine(2024)10.1371/journal.pmed.1004360

N/A

0.439DataRank · unranked

9 citations

Erica Andersen‐Nissen, Nicole Grunenberg, One Dintwe, Faatima Laher Omar, Jia Jin Kee +29 more

A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa

PLoS ONE(2020)10.1371/journal.pone.0231086

N/A

0.434DataRank · unranked

17 citations

Stefanie Hornschuh, Mamakiri Khunwane, Lerato M. Makhale, Kennedy Otwombe, Cecilia Morgan +9 more

Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad434

N/A

0.395DataRank · unranked

7 citations

Fatima Laher, One Dintwe, Monde Muyoyeta, Allan C. deCamp, Zonglin He +27 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

EClinicalMedicine(2025)10.1016/j.eclinm.2024.103054

N/A

0.269DataRank · unranked

5 citations

Asa Tapley, Aaron Hudson, Sufia Dadabhai, Bo Zhang, Nyaradzo Mgodi +93 more

A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials

Emerging Microbes & Infections(2025)10.1080/22221751.2025.2485317

N/A

0.260DataRank · unranked

4 citations

Shuying Sue Li, Elena Giorgi, LaTonya D. Williams, One Dintwe, Lindsay N. Carpp +34 more

Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa

AIDS and Behavior(2023)10.1007/s10461-023-04025-z

N/A

0.208DataRank · unranked

3 citations

Fatima Laher, Athmanundh Dilraj, Philip Smith, Glenda Gray, Doug Grove +16 more

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1–2 randomized double-blind placebo-controlled trial

PLOS Global Public Health(2024)10.1371/journal.pgph.0003319

N/A

0.108DataRank · unranked

1 citations

Fatima Laher, Linda‐Gail Bekker, Kelly E. Seaton, Mary Allen, Stephen De Rosa +27 more

Use of Varied Screening Risk Criteria and HIV Incidence in Phase 1 and 2 HIV Vaccine Trials in South Africa

AIDS and Behavior(2022)10.1007/s10461-022-03867-3

N/A

0DataRank · unranked

1 citations

Kennedy Otwombe, Ofentse Mokwena, Linda‐Gail Bekker, Mary Allen, Fatima Laher

Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial

PLoS ONE(2021)10.1371/journal.pone.0241708

N/A

0DataRank · unranked

10 citations

Kennedy Otwombe, Koleka Mlisana, Maphoshane Nchabeleng, Mary Allen, James G. Kublin +6 more

Data quality in an HIV vaccine efficacy clinical trial in South Africa: through natural disasters and with discipline

BMC Medical Research Methodology(2023)10.1186/s12874-023-01967-9

Top 100%

0DataRank

Top 100%0 citations

Mookho Malahleha, Shelly Ramirez, William Brumskine, Kennedy Otwombe, Zoe Moodie +2 more

Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk

PLoS Pathogens(2021)10.1371/journal.ppat.1009363

N/A

0DataRank · unranked

30 citations

Andrew Fioré-Gartland, Lamar M. Fleming, Lindsay N. Carpp, Anneta Naidoo, Michael S. Harper +13 more

Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study

EBioMedicine(2024)10.1016/j.ebiom.2024.105320

N/A

0DataRank · unranked

16 citations

Janine van Duijn, One Dintwe, Jack Heptinstall, Randy I. Burnham, Sheetal Sawant +93 more

Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature

Scientific Reports(2020)10.1038/s41598-020-69007-w

N/A

0DataRank · unranked

10 citations

Kelly E. Seaton, Michael S. Piepenbrink, John Hural, Paul Goepfert, Fatima Laher +11 more

Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses

Viruses(2024)10.3390/v16091365

N/A

0DataRank · unranked

2 citations

S. Munir Alam, Erica Andersen‐Nissen, Lindsay N. Carpp, One Dintwe, Britta Flach +12 more

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

PLoS Medicine(2020)10.1371/journal.pmed.1003117

N/A

0DataRank · unranked

14 citations

Stephen R. Walsh, Fatima Laher, Lucas Maganga, Michael E. Herce, Sarita Naidoo +28 more

HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens

Scientific Reports(2020)10.1038/s41598-020-57491-z

N/A

0DataRank · unranked

24 citations

Fatima Laher, Zoe Moodie, Arthur S. McMillan, Rachel L. Spreng, Peter B. Gilbert +15 more

Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV

Nature Communications(2025)10.1038/s41467-025-63948-4

N/A

0DataRank · unranked

1 citations

Bo Zhang, Caroline Brackett, Peter Elyanu, Asa Tapley, Sufia Dadabhai +95 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

UNC Libraries(2025)10.17615/19xw-z883

N/A

0DataRank · unranked

0 citations

José A. Hidalgo, Fatima Laher, John Hural, Nicole L. Yates, Caroline Brackett +40 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

EBioMedicine(2023)10.1016/j.ebiom.2023.104590

N/A

0DataRank · unranked

33 citations

Yunda Huang, Shelly Karuna, Jack Heptinstall, Caroline Brackett, Kelvin Chiong +40 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

UNC Libraries(2025)10.17615/p4hj-9n46

N/A

0DataRank · unranked

0 citations

Jia Jin Kee, Mubiana Inambao, Essack Mitha, Dishiki Kalonji, William Brumskine +76 more

Fatima Laher

Indexed papers

Top data-sharing exemplar

Papers